Marchesini G, Day CP, Dufour JF et al (2016) EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 64(6):1388–1402. https://doi.org/10.1016/J.JHEP.2015.11.004
Article
Google Scholar
Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 34(3):274–285. https://doi.org/10.1111/J.1365-2036.2011.04724.X
Article
CAS
PubMed
Google Scholar
Chalasani N, Younossi Z, Lavine JE et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 67(1):328–357. https://doi.org/10.1002/HEP.29367
Article
PubMed
Google Scholar
Association AD (2020) 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes—2020. Diabetes Care. 43(Supplement 1):S37–S47. https://doi.org/10.2337/DC20-S004
Article
Google Scholar
Chamberlain JJ, Rhinehart AS, Shaefer CF, Neuman A (2016) Diagnosis and management of diabetes: synopsis of the 2016 American diabetes association standards of medical care in diabetes. Ann Intern Med. 164(8):542–552. https://doi.org/10.7326/M15-3016
Article
PubMed
Google Scholar
Tanaka K, Takahashi H, Hyogo H et al (2019) Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver disease. Hepatol Res. 49(3):296–303. https://doi.org/10.1111/HEPR.13282
Article
CAS
PubMed
Google Scholar
Chen C, Zhu Z, Mao Y et al (2020) HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels. Biosci Rep. 40(1). https://doi.org/10.1042/BSR20193996
Yang SH, Du Y, Li XL et al (2017) Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in diabetics with coronary artery disease. Am J Med Sci. 354(2):117–124. https://doi.org/10.1016/J.AMJMS.2017.03.032
Article
PubMed
Google Scholar
Wu L, Parhofer KG (2014) Diabetic dyslipidemia. Metabolism. 63(12):1469–1479. https://doi.org/10.1016/J.METABOL.2014.08.010
Article
CAS
PubMed
Google Scholar
MR de A S, M de FF de M D, de JEM M-F, de MST A (2012) Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol. 49(1):89–96. https://doi.org/10.1590/S0004-28032012000100015
Article
Google Scholar
Akhtar DH, Iqbal U, Vazquez-Montesino LM, Dennis BB, Ahmed A (2019) Pathogenesis of insulin resistance and atherogenic dyslipidemia in nonalcoholic fatty liver disease. J Clin Transl Hepatol. 7(4):362–370. https://doi.org/10.14218/JCTH.2019.00028
Article
PubMed
PubMed Central
Google Scholar
Murguía-Romero M, Jiménez-Flores JR, Sigrist-Flores SC et al (2013) Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J Lipid Res. 54(10):2795–2799. https://doi.org/10.1194/JLR.M040584
Article
PubMed
PubMed Central
Google Scholar
Turak O, Afşar B, Ozcan F et al (2016) The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict new cardiovascular events in essential hypertensive patients. J Clin Hypertens. 18(8):772–777. https://doi.org/10.1111/JCH.12758
Article
CAS
Google Scholar
Onat A, Can G, Kaya H, Hergenç G (2010) “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein−cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 4(2):89–98. https://doi.org/10.1016/J.JACL.2010.02.005
Article
PubMed
Google Scholar
Fan N, Peng L, Xia Z et al (2019) Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. Lipids Heal Dis 181(1):1–6. https://doi.org/10.1186/S12944-019-0986-7
Article
Google Scholar
Masroor M, Haque Z (2021) HbA1C as a biomarker of non-alcoholic fatty liver disease: comparison with anthropometric parameters. J Clin Transl Hepatol. 9(1):15. https://doi.org/10.14218/JCTH.2019.00046
Article
PubMed
PubMed Central
Google Scholar
Sharma R, Sinha S, Danishad KA et al (2009) Investigation of hepatic gluconeogenesis pathway in non-diabetic Asian Indians with non-alcoholic fatty liver disease using in vivo (31P) phosphorus magnetic resonance spectroscopy. Atherosclerosis. 203(1):291–297. https://doi.org/10.1016/J.ATHEROSCLEROSIS.2008.06.016
Article
CAS
PubMed
Google Scholar
Lin TC, Lee HM, Seo HN et al (2018) Correlation between non-alcoholic fatty liver disease and hemoglobin A1c level in adult males without diabetes. Korean J Fam Pract. 8(1):131–135. https://doi.org/10.21215/KJFP.2018.8.1.131
Article
Google Scholar
Diabetes Trials Unit: HOMA Calculator News archive. Accessed July 26, 2021. http://www.dtu.ox.ac.uk/generic/newsarchive.php?Study=91
Gore RM, Levine MS. Textbook of Gastrointestinal Radiology (NEED PHYSICAL COPY). Published online 2008. Accessed 26 Jul 2021. http://ucs.cirqahosting.com/HeritageScripts/Hapi.dll/retrieve2?SearchTerm0=001x000157079&Dispfmt=F
Cai J, Zhang X-J, Li H (2019) Progress and challenges in the prevention and control of nonalcoholic fatty liver disease. Med Res Rev. 39(1):328–348. https://doi.org/10.1002/MED.21515
Article
PubMed
Google Scholar
Paschos P, Paletas K (2009) Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 13(1):9 Accessed 26 Jul 2021. /pmc/articles/PMC2633261/
CAS
PubMed
PubMed Central
Google Scholar
Wong CA, Araneta MRG, Barrett-Connor E, Alcaraz J, Castañeda D, Macera C (2008) Probable NAFLD, by ALT levels, and diabetes among Filipino-American Women. Diabetes Res Clin Pract. 79(1):133–140. https://doi.org/10.1016/J.DIABRES.2007.07.012
Article
CAS
PubMed
Google Scholar
Klisic A, Kavaric N, Ninic A (2019) Predictive values of serum uric acid and alanine-aminotransferase for fatty liver index in Montenegrin population. J Med Biochem. 38(4):407. https://doi.org/10.2478/JOMB-2019-0001
Article
CAS
PubMed
PubMed Central
Google Scholar
SM Al H, AA Al S, Mahfouz AA, Awadalla NJ, Musa MJ, Patel A (2020) Clinical and biochemical predictors of nonalcoholic fatty liver disease among type 2 diabetes mellitus patients at primary health care level in South Western Saudi Arabia. Diagnostics 10:809. https://doi.org/10.3390/DIAGNOSTICS10100809
Article
Google Scholar
Önal Z, Atasayan V, Gürbüz T, Hepkaya E, Nuhoğlu C (2014) Association of glycosylated hemoglobin (HbA1c) levels with Iinsulin resistance in obese children. Afr Health Sci. 14(3):533–538. https://doi.org/10.4314/ahs.v14i3.6
Article
PubMed
PubMed Central
Google Scholar
Kitade H, Chen G, Ni Y, Ota T (2017) Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments. Nutr 9:387. https://doi.org/10.3390/NU9040387
Article
Google Scholar
Stephen S, Baranova A, Younossi ZM et al (2014) Nat Rev Dis Primers 6(2):163–171. https://doi.org/10.1586/EGH.11.97
Article
Google Scholar
Bugianesi E, Gastaldelli A, Vanni E et al (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetol 48((4):634–642. https://doi.org/10.1007/S00125-005-1682-X
Article
CAS
Google Scholar
Hu DS, Zhu SH, Li X et al (2019) Association between hemoglobin glycation index and NAFLD in Chinese nondiabetic individuals. Can. J Gastroenterol Hepatol. 2019. https://doi.org/10.1155/2019/8748459
Bae JC, Cho YK, Lee WY et al (2010) Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol. 105(11):2389–2395. https://doi.org/10.1038/AJG.2010.275
Article
CAS
PubMed
Google Scholar
D’Adamo E, Giannini C, Chiavaroli V et al (2011) What is the significance of soluble and endogenous secretory receptor for advanced glycation end products in liver steatosis in obese prepubertal children? Antioxid Redox Signal 14(6):1167–1172. https://doi.org/10.1089/ARS.2010.3719https://home.liebertpub.com/ars
Article
PubMed
Google Scholar
Fracanzani AL, Valenti L, Bugianesi E et al (2008) Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 48(3):792–798. https://doi.org/10.1002/HEP.22429
Article
CAS
PubMed
Google Scholar
Palma-Duran SA, Kontogianni MD, Vlassopoulos A et al (2018) Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults. Metabolism. 83:120–127. https://doi.org/10.1016/J.METABOL.2018.01.023
Article
CAS
PubMed
Google Scholar
Cantero I, Abete I, JM del B et al (2018) Changes in lysophospholipids and liver status after weight loss: the RESMENA study. Nutr Metab 15(1):1–11. https://doi.org/10.1186/S12986-018-0288-5
Article
Google Scholar
Polsky S, Ellis SL (2015) Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 22(4):277–282. https://doi.org/10.1097/MED.0000000000000170
Article
CAS
PubMed
Google Scholar
Speliotes EK, Massaro JM, Hoffmann U et al (2010) Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham heart study. Hepatology. 51(6):1979–1987. https://doi.org/10.1002/HEP.23593
Article
CAS
PubMed
Google Scholar
Foster T, Anania FA, Li D, Ronit Katz, Budoff M. The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). doi:https://doi.org/10.1007/s10620-013-2652-7
Fukuda Y, Hashimoto Y, Hamaguchi M et al (2016) Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int. 36(5):713–720. https://doi.org/10.1111/LIV.12977
Article
CAS
PubMed
Google Scholar
Zhou M, Zhu L, Cui X et al (2016) The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of β cell function in a Chinese population with different glucose tolerance status. Lipids Heal Dis 15(1):1–9. https://doi.org/10.1186/S12944-016-0270-Z
Article
Google Scholar
Lucero D, Miksztowicz V, Macri V et al (2015) Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α. Clín Invest Arterioscler. 27(4):167–174. https://doi.org/10.1016/J.ARTERI.2014.11.002
Article
Google Scholar